Leading our way back to the ambitious research collaboration, Human Genome Project has paved ways in transforming biology and biological discovery. As a result of which, the fundamentals of Genomics and Proteomics have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. The swift growth in high throughput technologies used for genomic and proteomic profiling has factored breakthroughs for a much-anticipated personalized medicine approach for complex diseases.
MarketsandMarkets is delighted to announce its Next-Gen Genomics and Proteomics Conference scheduled to be held on 9th - 10th March 2023 in London,UK. The conference will assimilate diverse sessions on Functional genomics and Organellar Proteomics in Biomedicine, Applied and Translational genomics, Epigenomics in Systems Biology, Immune Phenotyping – Flowcytometry and Immuno Metabolic Markers- Polygenic Risk Scores, Next Generation Sequencing and Single Cell Sequencing for Disease Diagnosis, Electrospray Mass Spectrometry-based Biomarkers, Multidimensional Liquid Chromatography in Clinical Proteomics, Genome Wide Variant Data and Application of Omics in Protein – Protein Interaction. The event encompasses networking sessions, panel discussions, solutions, and services catering to Genomics and Proteomics research. The conference will constellate a full spectrum of experts, leaders, and stakeholders to share a board prospective the novel research and development in the field of multi-Omics research.
